Cardiogen is a synthetic tetrapeptide bioregulator frequently utilized in pre-clinical research to study myocardial cell regulation, fibroblast activity modulation, protein synthesis normalization, and epigenetic effects on cardiac tissue. This research-grade peptide is manufactured under strict GMP-compliant standards and supplied as a lyophilized powder to deliver exceptional purity, stability, and consistency for experimental use.
Designed exclusively for preclinical investigations, every batch of Cardiogen undergoes thorough quality testing and comes with full documentation, including a Certificate of Analysis (COA), purity verification, and structural confirmation.
Scientific Overview
Cardiogen interacts with gene promoter regions and cellular mechanisms in cardiac-related systems within research environments. Preclinical studies indicate Cardiogen’s potential influence in the following areas:
- Modulation of myocardial cell proliferation and protein synthesis pathways
- Regulation of fibroblast maturation and extracellular matrix dynamics
- Influence on apoptotic signaling markers in cardiac models
- Support for tissue remodeling and recovery mechanisms in stress conditions
- Normalization of metabolic and contractile functions in aging cardiac explants
Why Researchers Choose Our Cardiogen
Laboratories seeking reliable Cardiogen research peptide benefit from our manufacturing emphasis on reproducibility and scientific accuracy. Each batch is verified for:
- Purity ≥99% by HPLC
- Structural identity via mass spectrometry
- Third-party Certificate of Analysis (CoA) available per lot
For Research Use Only. Statements regarding Cardiogen have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
Explore our testing protocols in About Peptides > Rigorous Testing.
Research-Referenced Functional Attributes
(Based on existing preclinical and literature data—not intended as claims of therapeutic use)
- Stimulation of cardiomyocyte proliferation while modulating fibroblast activity in myocardial tissue cultures from young and aged models
- Reduction of p53 expression potentially linked to decreased apoptosis in cardiac cells
- Normalization of gene expression related to contractile proteins and mitochondrial bioenergetics in aging cardiomyocytes
- Support for investigations into cardiac remodeling and scar formation reduction in stress or injury models
- Potential modulation of oxidative stress responses and protein synthesis in myocardial systems
- Examination of tissue-specific effects on heart function in peptide bioregulator studies
